|
|
|
Liminal Biosciences Inc (LMNL) |
|
Liminal Biosciences Inc
LMNL's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Liminal Biosciences Inc 's sales fell
by -37.64 % in IV. Quarter 2022 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -3.56 %
Liminal Biosciences Inc 's net profit deacreased by -94.91 % in IV. Quarter 2022 year on year, to $0 millions.
• More on LMNL's Growth
|
|
Liminal Biosciences Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Liminal Biosciences Inc PEG ratio is at | | | |
